Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Coeloglossum viride extract protective in models of brain ischemia

March 16, 2009

GPR3 identified as a new pharmacological target for Alzheimer's disease

March 16, 2009

Novartis presents novel GABA-A receptor ligands

March 13, 2009

Novel beta-secretase inhibitors claimed by CoMentis and Purdue Research Foundation

March 13, 2009

Neurogen presents novel heteroaryl amide analogues

March 13, 2009

Preliminary findings suggest AD-01, AD-02 vaccines are safe in Alzheimer's disease patients

March 13, 2009

Dimebolin safe, improves cognition in Huntington's disease patients

March 13, 2009

FDA approves Insmed's Iplex for ALS under IND applications

March 13, 2009

Targacept to discontinue development of TC-6499 for neuropathic pain

March 12, 2009

Medicure cleared to commence phase II Avastrem trial for tardive dyskinesia

March 12, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...